Bullish
ImmuCell (NASDAQ: ICCC) investors approve directors, pay plan, auditor
ImmuCell Corporation's stockholders approved all proposals at their 2026 annual meeting, including the election of seven directors
ImmuCell Corporation's stockholders approved all proposals at their 2026 annual meeting, including the election of seven directors